News
- American Kidney Fund Announces Support from Vertex Pharmaceuticals Inc. to Raise Awareness and Increase Education of the APOL1 Gene and its Link to Kidney Disease
03/29/2022 / 15:00 - GlobeNewswire
-
- The Vertex Company wins prime position on US Air Force rapid development contract
03/29/2022 / 14:30 - GlobeNewswire
-
- SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates IIN, VEC, VOLT, TGNA
03/29/2022 / 02:17 - GlobeNewswire
-
- TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
03/24/2022 / 21:26 - GlobeNewswire
-
- BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Emclaire Financial Corp. (Nasdaq – EMCF), Avista Public Acquisition Corp. II (Nasdaq - AHPA), Vectrus, Inc. (NYSE - VEC), Intricon Corporation (Nasdaq - IIN)
03/24/2022 / 16:20 - GlobeNewswire
-
- Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call and Business Update
03/24/2022 / 12:30 - GlobeNewswire
-
- SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates VEC, IIN, WLL, OAS
03/22/2022 / 17:31 - GlobeNewswire
-
- Kizoo Portfolio Company Revel Pharmaceuticals Announces $8.4M Seed to Develop Repairing-Based Approaches to Reversing Aging
03/17/2022 / 13:00 - GlobeNewswire
-
- Dura Software Announces the Appointment of Alex Rozek to Board of Directors
03/16/2022 / 16:15 - GlobeNewswire
-
- EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
03/16/2022 / 12:00 - GlobeNewswire
Real-time